ChemoCentryx
CCXI
#3702
Rank
S$4.76 B
Marketcap
S$66.32
Share price
0.00%
Change (1 day)
29.62%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: S$4.76 Billion

On November 25, 2022 ChemoCentryx had a market cap of S$4.76 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022S$5.01 B45.41%
2021S$3.44 B-39.2%
2020S$5.66 B76.52%
2019S$3.21 B325.42%
2018S$0.75 B94.53%
2017S$0.38 B-24.2%
2016S$0.51 B1.13%
2015S$0.50 B29.12%
2014S$0.39 B24.62%
2013S$0.31 B-35.31%
2012S$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$695.10 B 14,472.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$194.47 B 3,977.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$452.41 B 9,384.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$237.88 B 4,887.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$35.58 B 646.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$356.05 B 7,364.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$153.15 B 3,110.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$143.02 B 2,898.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$47.51 B 896.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel